Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


The therapeutic antibody eculizumab caught in action


In collaboration with Alexion Pharmaceuticals, Inc., scientists from Aarhus University have used X-rays to understand how the therapeutic antibody eculizumab prevents our immune system from destroying red blood cells and damaging kidney tissue.

The scientists in Aarhus studied an important protein from the innate immune system called C5 which is cleaved by enzymes when pathogens invade our body as a defense mechanism. The two C5 fragments formed through this cleavage recruit immune cells to fight the pathogen and may directly kill it.

The atomic structure of C5 (blue) bound to the C5-binding part of eculizumab (yellow) shows how eculizumab blocks the cleavage of C5 in blood circulation. This rescues the red blood cells (red disks) from disruption. In real life the proteins are 500 times smaller than the red blood cells.

Credit: Janus Asbjørn Schatz-Jakobsen

Our own cells are protected against damage caused by cleavage of the C5 protein. But in two rare diseases called paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), this protection is lost due to mutations in our DNA. Patients suffer as their red blood cells and cells in the kidney are continuously damaged, and the diseases are life-threatening.

The global biopharmaceutical company Alexion, headquartered in the U.S., has developed a therapeutic antibody called eculizumab that prevents the cleavage of C5 and thereby treats the two diseases.

The research was performed by PhD student Janus Asbjørn Schatz-Jakobsen and Professor Gregers Rom Andersen at the Department of Molecular Biology and Genetics at Aarhus University in Denmark in collaboration with scientists at Alexion and is now published in The Journal of Immunology with a figure from the article on the cover of the July issue.

Description of tthe research project

Janus first purified C5 from human blood plasma and then mixed it with a fragment of the eculizumab antibody prepared by Alexion solely for this collaboration. After many attempts, Janus managed to form crystals containing the complex between C5 and the antibody fragment. In the following year, more than 200 crystals were investigated by Janus using very intense X-ray radiation at large international facilities in France.

After a total of 18 months with careful and tedious work, Janus was finally able to describe the atomic structure of C5 bound to the eculizumab fragment. This structure revealed that the antibody creates a physical barrier that prevents the cleaving enzymes from forming contacts with C5.

On the other side of the Atlantic Ocean, scientists at Alexion in parallel performed biochemical experiments in which the function of antibodies carrying mutations in regions responsible for binding to C5 were compared to the normal eculizumab antibody.

Janus Asbjørn Schatz-Jakobsen explains: "When I had finished my atomic model and was awaiting the results from Alexion for comparison, I felt almost like a small child waiting for X-mas eve. When the result arrived by email, I could quickly confirm that there was an excellent agreement between my results and those obtained by the Alexion scientists, which confirmed that my model was correct. It was quite a relief and the results from Alexion also made me discover new exciting aspects of my atomic structure that I had not noticed yet."

The new research has also helped the scientists at Aarhus University to better understand the mechanism by which C5 is cleaved by enzymes in the absence of eculizumab. At Alexion, the atomic structure is now used as a framework to understand in details how their therapeutic antibody works and treats the two diseases.

Read the article published in The Journal of Immunology.

For further information, please contact

Professor Gregers Rom Andersen
mobile: 45-3025-6646

PhD student Janus Asbjørn Schatz-Jakobsen
Tel. 45-8715-4201
Department of Molecular Biology and Genetics
Aarhus University, Denmark 

Professor Gregers Rom Andersen | EurekAlert!

More articles from Life Sciences:

nachricht Gene therapy shows promise for treating Niemann-Pick disease type C1
27.10.2016 | NIH/National Human Genome Research Institute

nachricht 'Neighbor maps' reveal the genome's 3-D shape
27.10.2016 | International School of Advanced Studies (SISSA)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

How nanoscience will improve our health and lives in the coming years

27.10.2016 | Materials Sciences

OU-led team discovers rare, newborn tri-star system using ALMA

27.10.2016 | Physics and Astronomy

'Neighbor maps' reveal the genome's 3-D shape

27.10.2016 | Life Sciences

More VideoLinks >>>